Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups
2019 · Nature · 439 citations
https://doi.org/10.1038/s41586-019-1007-8
J
Jennifer L. Caswell‐Jin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
100
Papers
2.9K
Citations
23
h-index
31
i10-index
Jennifer L. Caswell‐Jin is an academic researcher from Stanford Medicine. The author has contributed to research in topics: Breast Cancer Treatment Studies & BRCA gene mutations in cancer & Global Cancer Incidence and Screening. The author has an h-index of 23, co-authored 85 publications.
ORCID: 0000-0002-5711-8355Papers by this author
worksChange in Survival in Metastatic Breast Cancer with Treatment Advances: Meta-Analysis and Systematic Review
2018 · JNCI Cancer Spectrum · 319 citations
https://doi.org/10.1093/jncics/pky062
Analysis of Breast Cancer Mortality in the US—1975 to 2019
2024 · JAMA · 244 citations
https://doi.org/10.1001/jama.2023.25881
Genome-wide association study of breast cancer in Latinas identifies novel protective variants on 6q25
2014 · Nature Communications · 144 citations
https://doi.org/10.1038/ncomms6260
Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)
2020 · Nature Communications · 65 citations
https://doi.org/10.1038/s41467-020-19494-2
Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy
2019 · Nature Communications · 60 citations
https://doi.org/10.1038/s41467-019-08593-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat